Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP1S mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1S mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Map1s (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MAP1S mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MAP1S mRNA | CTD | PMID:32145629 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Map1s (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP1S mRNA | CTD | PMID:21570461 | 2-methylcholine | affects expression | ISO | MAP1S (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of MAP1S mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Map1s (Mus musculus) | 6480464 | bisphenol S results in increased methylation of MAP1S exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1S mRNA | CTD | PMID:36041667 | 4,4'-sulfonyldiphenol | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | bisphenol S results in increased expression of MAP1S protein | CTD | PMID:34186270 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MAP1S mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Tretinoin results in increased expression of MAP1S mRNA | CTD | PMID:33167477 | aristolochic acid A | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MAP1S mRNA | CTD | PMID:33212167 | benzatropine | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Benztropine results in increased expression of MAP1S protein | CTD | PMID:34122009 | benzene | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Benzene results in increased expression of MAP1S mRNA | CTD | PMID:19162166 | benzo[a]pyrene | decreases expression | ISO | Map1s (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MAP1S mRNA | CTD | PMID:27195522 | benzo[a]pyrene | decreases methylation | ISO | Map1s (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of MAP1S exon | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | MAP1S (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MAP1S promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Map1s (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MAP1S mRNA | CTD | PMID:22228805 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MAP1S mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1S mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MAP1S protein | CTD | PMID:31675489 and PMID:34186270 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MAP1S mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1S mRNA | CTD | PMID:36041667 | bisphenol F | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | bisphenol F results in increased expression of MAP1S protein | CTD | PMID:34186270 | cadmium atom | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1S mRNA | CTD | PMID:35301059 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of MAP1S promoter | CTD | PMID:22457795 | cadmium dichloride | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1S mRNA | CTD | PMID:35301059 | caffeine | affects phosphorylation | ISO | MAP1S (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of MAP1S protein | CTD | PMID:35688186 | CGP 52608 | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAP1S gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Map1s (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MAP1S mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAP1S gene | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MAP1S mRNA | CTD | PMID:27594783 | clofibrate | decreases expression | ISO | Map1s (Mus musculus) | 6480464 | Clofibrate results in decreased expression of MAP1S mRNA | CTD | PMID:17585979 | clozapine | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Clozapine results in increased expression of MAP1S protein | CTD | PMID:34122009 | coumarin | affects phosphorylation | ISO | MAP1S (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of MAP1S protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MAP1S mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of MAP1S mRNA | CTD | PMID:23640034 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of MAP1S mRNA | CTD | PMID:29391264 | enzyme inhibitor | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MAP1S protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Map1s (Mus musculus) | 6480464 | Ethanol affects the splicing of MAP1S mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | FR900359 | affects phosphorylation | ISO | MAP1S (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of MAP1S protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MAP1S mRNA | CTD | PMID:33387578 | ivermectin | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MAP1S protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAP1S gene | CTD | PMID:20938992 | N-nitrosodiethylamine | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MAP1S gene | CTD | PMID:23968726 | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of MAP1S mRNA | CTD | PMID:23665939 | ozone | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP1S mRNA | CTD | PMID:35430440 | paracetamol | affects expression | ISO | Map1s (Mus musculus) | 6480464 | Acetaminophen affects the expression of MAP1S mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAP1S mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of MAP1S mRNA | CTD | PMID:22230336 and PMID:29067470 | perfluorooctanoic acid | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of MAP1S protein | CTD | PMID:26879310 | piperonyl butoxide | multiple interactions | ISO | Map1s (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MAP1S gene | CTD | PMID:23968726 | sodium arsenite | decreases expression | ISO | MAP1S (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MAP1S mRNA | CTD | PMID:34032870 | sodium arsenite | multiple interactions | ISO | MAP1S (Homo sapiens) | 6480464 | sodium arsenite promotes the reaction [MAP1S protein binds to CAPRIN1 protein] | CTD | PMID:33939924 | temozolomide | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Temozolomide results in increased expression of MAP1S mRNA | CTD | PMID:31758290 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAP1S mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP1S mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAP1S mRNA | CTD | PMID:34492290 | Triptolide | increases expression | ISO | Map1s (Mus musculus) | 6480464 | triptolide results in increased expression of MAP1S mRNA | CTD | PMID:32835833 | tungsten | decreases expression | ISO | Map1s (Mus musculus) | 6480464 | Tungsten results in decreased expression of MAP1S mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | MAP1S (Homo sapiens) | 6480464 | Urethane results in increased expression of MAP1S mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | MAP1S (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MAP1S gene | CTD | PMID:29154799 | |